European Commission’s Studies on Pharmaceutical Incentives

The European Commission is preparing an evidence-based analysis of the impact of the incentives on innovation, availability, and accessibility of medicinal products following the Council’s conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States of 17 June last year. For this purpose, (at least) three studies will be conducted:

  • Study on the legal aspects of the Supplementary Protection Certificates in the EU
  • Study on the economic impact of Supplementary Protection Certificates, pharmaceutical incentives and rewards in Europe
  • Paediatric study and report

Tagged with

Published 5. April 2017 in News EU